Oncologic outcomes of pathologic stage i lower rectal cancer with or without preoperative chemoradiotherapy: Are they comparable?

Surgery

Volumn 150, Issue 5, 2011, Pages 980-984

  Huh, Jung Wook ^a   Kim, Chang Hyun ^a   Kim, Hyeong Rok ^a   Kim, Young Jin ^a  

^a Chonnam National University Research Institute of Medical Sciences   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISEASE SEVERITY; EARLY CANCER; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREOPERATIVE RADIOTHERAPY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECTUM CANCER; RECTUM RESECTION; RECURRENCE RISK; TREATMENT RESPONSE;

CHEMORADIOTHERAPY; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREOPERATIVE CARE; PROSPECTIVE STUDIES; RECTAL NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 80054934926     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2011.06.018     Document Type: Article

References (19)

1. D. Sebag-Montefiore, R.J. Stephens, R. Steele, J. Monson, R. Grieve, and S. Khanna Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial Lancet 373 2009 811 820
2. R. Sauer, H. Becker, W. Hohenberger, C. Rodel, C. Wittekind, and R. Fietkau Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 2004 1731 1740
3. J.P. Gerard, O. Chapet, C. Nemoz, J. Hartweig, P. Romestaing, and R. Coquard Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy: the lyon R96-02 randomized trial J Clin Oncol 22 2004 2404 2409 (Pubitemid 41115397)
4. E. Kapiteijn, C.A. Marijnen, I.D. Nagtegaal, H. Putter, W.H. Steup, and T. Wiggers Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer N Engl J Med 345 2001 638 646
5. J.W. Huh, E.J. Jung, Y.A. Park, K.Y. Lee, and S.K. Sohn Sphincter-preserving operations following preoperative chemoradiation: an alternative to abdominoperineal resection for lower rectal cancer? World J Surg 32 2008 1116 1123
6. M.S. Roh, L.H. Colangelo, M.J. O'Connell, G. Yothers, M. Deutsch, and C.J. Allegra Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03 J Clin Oncol 27 2009 5124 5130
7. H.M. Quah, J.F. Chou, M. Gonen, J. Shia, D. Schrag, and L.B. Saltz Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation Cancer 113 2008 57 64 (Pubitemid 351976386)
8. J.G. Guillem, D.B. Chessin, A.M. Cohen, J. Shia, M. Mazumdar, and W. Enker Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer Ann Surg 241 2005 829 836
9. A. Habr-Gama, R.O. Perez, W. Nadalin, S.C. Nahas, U. Ribeiro Jr. , and E.S.A.H. Silva Jr. Long-term results of preoperative chemoradiation for distal rectal cancer correlation between final stage and survival J Gastrointest Surg 9 2005 90 99
10. L. Ruo, S. Tickoo, D.S. Klimstra, B.D. Minsky, L. Saltz, and M. Mazumdar Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy Ann Surg 236 2002 75 81 (Pubitemid 34686453)
11. J.W. Huh, and H.R. Kim Postoperative chemotherapy after neoadjuvant chemoradiation and surgery for rectal cancer: is it essential for patients with ypT0-2N0? J Surg Oncol 100 2009 387 391
12. J.W. Huh, H.R. Kim, and Y.J. Kim Anastomotic leakage after laparoscopic resection of rectal cancer: the impact of fibrin glue Am J Surg 199 2010 435 441
13. J.W. Huh, H.R. Kim, and Y.J. Kim Proliferating cell nuclear antigen as a prognostic factor after total mesorectal excision of stage II-III rectal cancer Ann Surg Oncol 16 2009 1494 1500
14. H. Bouzourene, F.T. Bosman, W. Seelentag, M. Matter, and P. Coucke Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy Cancer 94 2002 1121 1130 (Pubitemid 34150868)
15. A. Habr-Gama, P.M. de Souza, U. Ribeiro Jr. , W. Nadalin, R. Gansl, and A.H. Sousa Jr. Low rectal cancer: impact of radiation and chemotherapy on surgical treatment Dis Colon Rectum 41 1998 1087 1096 (Pubitemid 28432448)
16. P. Luna-Pérez, B. Trejo-Valdivia, S. Labastida, S. Garcia-Alvarado, D.F. Rodriguez, and S. Delgado Prognostic factors in patients with locally advanced rectal adenocarcinoma treated with preoperative radiotherapy and surgery World J Surg 23 1999 1069 1074
17. J. Garcia-Aguilar, E. Hernandez de Anda, P. Sirivongs, S.H. Lee, R.D. Madoff, and D.A. Rothenberger A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision Dis Colon Rectum 46 2003 298 304 (Pubitemid 36331646)
18. J.W. Huh Postoperative adjuvant chemotherapy in patients with ypN+ after preoperative chemoradiation for rectal cancer: Need for randomized trials J Surg Oncol 2011 Apr 25 10.1002/jso.21952 [Epub ahead of print]
19. Y.J. Park, B.R. Oh, S.W. Lim, J.W. Huh, J.K. Joo, and Y.J. Kim Clinical significance of tumor regression grade in rectal cancer with preoperative chemoradiotherapy J Korean Soc Coloproctol 26 2010 279 286